Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Lanreotide for the Prolonged Control of Carcinoid Syndrome (CS) in Somatostatin Analog (SSA)-Naive or -Experienced Patients Wolin, E., Fisher, G., Lowenthal, S., Mirakhur, B., Pommier, R., Shaheen, M., Vinik, A. LIPPINCOTT WILLIAMS & WILKINS. 2019: 455–56
View details for Web of Science ID 000462541800125